(3Z)-3-benzylidene-4,5,6,7-tetrahydroisobenzofuran-1(3H)-one | 122135-92-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 异苯并呋喃
• 英文名称: (3Z)-3-benzylidene-4,5,6,7-tetrahydroisobenzofuran-1(3H)-one
• 英文别名: (3Z)-4,5,6,7-tetrahydro-3-benzylideneisobenzofuran-1(3H)-one；(Z)-3-penzylidene-4,5,6,7-tetrahydroisobenzofuran-1(3H)-one；3-benzylidene-4,5,6,7-tetrahydro-2-benzofuran-1(3H)-one；3-Benzyliden-4,5,6,7-tetrahydro-phthalid；(3Z)-3-benzylidene-4,5,6,7-tetrahydro-2-benzofuran-1-one
• CAS: 122135-92-6
• 化学式: C₁₅H₁₄O₂
• 分子量: 226.275
• InChiKey: UXIFIKDWQDPZPF-UVTDQMKNSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  17
• 可旋转键数：
  1
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.27
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  2-溴-1-环己烯-1-甲醛 在 sodium chlorite 、 copper(l) iodide 、 三正丁胺 、 palladium 10% on activated carbon 、 双氧水 、 三苯基膦 作用下， 以 1,4-二氧六环 为溶剂， 反应 20.0h， 生成 (3Z)-3-benzylidene-4,5,6,7-tetrahydroisobenzofuran-1(3H)-one
  参考文献：
  名称：

  Pd / C催化的β-溴-α，β-不饱和羧酸与末端炔烃的偶联和环化反应生成亚烷基呋喃酮

  摘要：

  钯催化的β-溴-α，β-不饱和羧酸与末端炔烃的偶合以及随后的区域选择性5 -exo-dig环化反应可产生高收率的（Z）-亚烷基呋喃酮。

  DOI：

  10.1016/j.jorganchem.2011.06.044

文献信息

• CuI/amino acid catalysis in coupling and cyclization of β-bromo-α,β-unsaturated carboxylic acids with terminal alkynes leading to alkylidenefuranones
  作者：Son Long Ho、Chan Sik Cho、Heung-Jin Choi、Ho-Sang Sohn

  DOI：10.1002/aoc.2963

  日期：2013.5

  β‐Bromo‐α,β‐unsaturated carboxylic acids are coupled and cyclized with terminal alkynes in DMF at 110°C in the presence of a catalytic amount of CuI and amino acid along with a base to give alkylidenefuranones in good yields. Similar reaction under microwave irradiation also gave alkylidenefuranones in higher yields. Copyright © 2013 John Wiley & Sons, Ltd.

  在催化量的CuI和氨基酸以及碱的存在下，在110°C的条件下，将β-溴-α，β-不饱和羧酸与末端炔在DMF中偶联并环化，以高收率得到亚烷基呋喃酮。在微波辐射下的类似反应也以更高的产率得到了亚烷基呋喃酮。版权所有©2013 John Wiley＆Sons，Ltd.
• A recyclable metal-organic framework MOF-199 catalyst in coupling and cyclization of β-bromo-α,β-unsaturated carboxylic acids with terminal alkynes leading to alkylidenefuranones
  作者：Son Long Ho、Il Chul Yoon、Chan Sik Cho、Heung-Jin Choi

  DOI：10.1016/j.jorganchem.2015.05.040

  日期：2015.8

  β-Bromo-α,β-unsaturated carboxylic acids react with terminal alkynes in DMF in the presence of a catalytic amount of metal-organic framework MOF-199 along with a base under microwave irradiation to afford the corresponding alkylidenefuranones in good yields. The catalytic system could be easily recovered and reused 5 times without any loss of catalytic activity.

  在微波辐射下，在催化量的金属有机骨架MOF-199和碱的存在下，β-溴-α，β-不饱和羧酸在DMF中与末端炔烃反应，以高收率得到相应的亚烷基呋喃酮。该催化体系可以容易地回收并重复使用5次，而不会损失任何催化活性。
• CuI/amino acid-catalyzed coupling and cyclization of β-bromo-α,β-unsaturated amides with terminal alkynes leading to (3<i>Z</i>)-3-alkylidenepyrrol-1-ones
  作者：Jong Ik Son、Chan Sik Cho、Heung-Jin Choi

  DOI：10.1002/aoc.2990

  日期：2013.7

  β‐Bromo‐α,β‐unsaturated amides are coupled and cyclized with terminal alkynes in DMF at 110 °C in the presence of a catalytic amount of CuI and amino acid along with a base to give the corresponding (3Z)‐3‐alkylidenepyrrol‐1‐ones in moderate to good yields. Copyright © 2013 John Wiley & Sons, Ltd.

  在催化量的CuI和氨基酸以及碱的存在下，在110°C的条件下，将β-溴-α，β-不饱和酰胺与末端炔在DMF中偶联并环化，得到相应的（3 Z）-3-亚烷基吡咯烷-1-酮，产率中等至良好。版权所有©2013 John Wiley＆Sons，Ltd.
• Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient
  申请人：Seko Takuya

  公开号：US20050085476A1

  公开（公告）日：2005-04-21

  Fused pyridazine derivatives represented by formula (I) or pharmaceutically acceptable salts thereof (wherein each symbol has the meaning as defined in the specification.). Because of inhibiting poly(ADP-ribose)polymerase, the compounds represented by formula (I) are useful as preventives and/or remedies for various ischemic diseases (in brain, cord, heart, digestive tract, skeletal muscle, retina, etc.), inflammatory diseases (inflammatory bowel disease, multiple cerebrosclerosis, arthritis, etc.), neurodegenerative diseases (extrapyramidal disorder, Alzheimer's disease, muscular dystrophy, lumbar spinal canal stenosis, etc.), diabetes, shock, head trauma, renal failure, hyperalgesia, etc. Moreover, these compounds are useful as agents against retroviruses (HIV etc.), sensitizers in treating cancer and immunosuppressants.

  公式(I)所代表的融合吡啶嗪衍生物或其药学上可接受的盐（其中每个符号的含义如说明书所定义）。由于抑制多聚腺苷酸核苷酸聚合酶，公式（I）所代表的化合物可用作各种缺血性疾病（在大脑、脊髓、心脏、消化道、骨骼肌、视网膜等处）、炎症性疾病（炎症性肠病、多发性硬化症、关节炎等）、神经退行性疾病（锥体外系障碍、阿尔茨海默病、肌萎缩症、腰椎管狭窄等）、糖尿病、休克、头部创伤、肾功能衰竭、高痛感等的预防和/或治疗剂。此外，这些化合物可用作抗逆转录病毒剂（HIV等）、癌症治疗敏感剂和免疫抑制剂。
• FUSED PYRIDAZINE DERIVATIVE COMPOUNDS AND DRUGS CONTAINING THESE COMPOUNDS AS THE ACTIVE INGREDIENT
  申请人：Seko Takuya

  公开号：US20080261947A1

  公开（公告）日：2008-10-23

  Fused pyridazine derivatives represented by formula (I) or pharmaceutically acceptable salts thereof (wherein each symbol has the meaning as defined in the specification.). Because of inhibiting poly(ADP-ribose)polymerase, the compounds represented by formula (I) are useful as preventives and/or remedies for various ischemic diseases (in brain, cord, heart, digestive tract, skeletal muscle, retina, etc.), inflammatory diseases (inflammatory bowel disease, multiple cerebrosclerosis, arthritis, etc.), neurodegenerative diseases (extrapyramidal disorder, Alzheimer's disease, muscular dystrophy, lumbar spinal canal stenosis, etc.), diabetes, shock, head trauma, renal failure, hyperalgesia, etc. Moreover, these compounds are useful as agents against retroviruses (HIV etc.), sensitizers in treating cancer and immunosuppressants.

  式（I）所表示的融合吡嗪衍生物或其药学上可接受的盐（其中每个符号的含义如规范中所定义）。由于抑制了聚(ADP-核糖)聚合酶，式（I）所表示的化合物可用作预防和/或治疗各种缺血性疾病（在大脑、脊髓、心脏、消化道、骨骼肌、视网膜等部位），炎症性疾病（炎症性肠病、多发性硬化症、关节炎等），神经退行性疾病（锥体外系障碍、阿尔茨海默病、肌萎缩症、腰椎管狭窄等），糖尿病、休克、头部创伤、肾功能衰竭、高痛感等。此外，这些化合物还可用作抗逆转录病毒剂（HIV等）、治疗癌症的增敏剂和免疫抑制剂。